Stock IMCC IM CANNABIS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News IM Cannabis Corp. Nasdaq

Equities

IMCC

CA44969Q3070

Delayed Nasdaq
Other stock markets
 08:01:08 24/05/2024 pm IST 		5-day change 1st Jan Change
0.605 USD +2.54% Intraday chart for IM Cannabis Corp. -10.85% +77.31%
08/05 Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024
08/05 IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
IM Cannabis : Transcript
PU
Transcript : IM Cannabis Corp., Q1 2024 Earnings Call, May 08, 2024
IM Cannabis : Financial Statements Q1 2024
PU
IM Cannabis : Management's Discussion and Analysis Q1 2024
PU
IM Cannabis Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K
PU
IM Cannabis Corp. and Vessel Brand, Inc. Partner to Bring Vessel Cannabis Accessories to the Israeli Market
CI
IM Cannabis, Avant Brands Sign BLK MKT's Licensing Deal for German Medical Cannabis Market
MT
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K
PU
Transcript : IM Cannabis Corp., 2023 Earnings Call, Mar 28, 2024
IM Cannabis Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
IM Cannabis Corp. Brief: Notes This Provides IMC Germany with a "Unique Opportunity" to further accelerate growth in 2024 after delivering 180% growth in 2023
MT
IM Cannabis Corp. Brief: Adds By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is Expected to deliver "Strong" growth
MT
IM Cannabis Corp. Brief: Says Expects "Accelerated Growth" in Germany from that Country's "Groundbreaking" Cannabis Legalization
MT
IM Cannabis Corp. Announces German Government's Final Approval of Legalizing Cannabis
CI
IM Cannabis : MONTHLY PROGRESS REPORT - Form 6-K
PU
IMC Announces Potential Reverse Merger With A Leading Clinical Cell Therapy Company
MT
IMC Announces Potential Reverse Merger with Kadimastem a leading Clinical cell therapy company
AQ
Kadimastem Ltd entered into a non-binding term sheet to acquire IM Cannabis Corp. in reverse merger transaction.
CI
Avant Brands Brief: Restructuring Loan Agreements to Extend Term and Decrease Payments
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. IMCC Stock
  4. IMCC Stock
  5. News IM Cannabis Corp.